Home  »  Company   »  DermTech Inc. (NASDAQ: DMTK) investors to reap big...

DermTech Inc. (NASDAQ: DMTK) investors to reap big returns again

DermTech Inc. (NASDAQ:DMTK) has a beta value of 1.63 and has seen 1.5 million shares traded in the last trading session. The company, currently valued at $162.11M, closed the last trade at $5.59 per share which meant it gained $1.07 on the day or 23.67% during that session. The DMTK stock price is -192.13% off its 52-week high price of $16.33 and 72.27% above the 52-week low of $1.55. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.73 million shares traded. The 3-month trading volume is 758.57K shares.

DermTech Inc. (NASDAQ:DMTK) trade information

Sporting 23.67% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Monday, 01/23/23 when the DMTK stock price touched $5.59 or saw a rise of 5.41%. Year-to-date, DermTech Inc. shares have moved 215.82%, while the 5-day performance has seen it change 16.46%. Over the past 30 days, the shares of DermTech Inc. (NASDAQ:DMTK) have changed 203.80%. Short interest in the company has seen 2.84 million shares shorted with days to cover at 6.71.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


DermTech Inc. (DMTK) estimates and forecasts

Figures show that DermTech Inc. shares have underperformed across the wider relevant industry. The company’s shares have lost -22.79% over the past 6 months, with this year growth rate of -44.28%, compared to 4.40% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2023 fiscal year revenue. Growth estimates for the current quarter are -39.70% and -6.80% for the next quarter. Revenue growth from the last financial year stood is estimated to be 60.30%.

7 analysts offering their estimates for the company have set an average revenue estimate of $4.97 million for the current quarter. 7 have an estimated revenue figure of $5.94 million for the next quarter concluding in Dec 2022. Year-ago sales stood $3.41 million and $3.17 million respectively for this quarter and the next, and analysts expect sales will grow by 45.70% for the current quarter and 87.70% for the next.

DMTK Dividends

DermTech Inc. is expected to release its next earnings report between February 27 and March 03 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

DermTech Inc. (NASDAQ:DMTK)’s Major holders

Insiders own 8.53% of the company shares, while shares held by institutions stand at 60.09% with a share float percentage of 65.69%. Investors are also buoyed by the number of investors in a company, with DermTech Inc. having a total of 180 institutions that hold shares in the company. The top two institutional holders are RTW Investments LP with over 3.12 million shares worth more than $17.28 million. As of Jun 29, 2022, RTW Investments LP held 10.38% of shares outstanding.

The other major institutional holder is UBS OConnor LLC, with the holding of over 2.95 million shares as of Jun 29, 2022. The firm’s total holdings are worth over $16.34 million and represent 9.82% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Northern Lights Fd Tr II-Invenomic Fd. As of Jun 29, 2022, the former fund manager holds about 2.83% shares in the company for having 0.85 million shares of worth $4.7 million while later fund manager owns 0.7 million shares of worth $5.74 million as of Jul 30, 2022, which makes it owner of about 2.33% of company’s outstanding stock.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts